IP Library Granted Patent US 10,493,380
Granted Patent B2
US 10,493,380 · App. 15/183,526 · Granted Dec 3, 2019

Chromatography medium

Inventors: Jan Bergstrom (Balinge, SE); Gunnar Glad (Uppsala, SE); Bo-Lennart Johansson (Uppsala, SE); Jean-Luc Maloisel (Uppsala, SE); Nils Norrman (Uppsala, SE); Tobias E. Soderman (Uppsala, SE)
Assignee: GE Healthcare BioProcess R&D AB
B01D15/327B01J20/285B01J20/287B01J20/28009B01J20/3212B01J20/3293B01J39/26C07K1/20C07K16/00C12N7/00G01N1/405C12N2760/16151
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,493,380
App. No.
15/183,526
Granted
Dec 3, 2019
Kind
B2
Abstract

The present invention is within the field of chromatography. More precisely, it relates to a novel chromatography medium, namely a hydrophobic medium provided with different lids excluding molecules over a certain size due to the porosity of the hydrophobic medium and/or the porosity of the lid. The invention also relates to use of the separation medium for purification of large molecules, which do not enter the separation medium, as well as small molecules, which enter the separation medium and are eluted from there.

Claims (18)

1. A method for separating at least one target substance from a sample,

the method comprising,

applying a sample comprising at least one target substance onto an agarose based separation medium, wherein the at least one target substance is selected from a virus and an antibody and wherein said separation medium comprises a porous core entity functionalized with hydrophobic octylamine ligands having a ligand density of greater than 90 μmole/mL, and a porous hydrophilic lid covering the core entity,

allowing molecules having a size of <60,000 D from the sample to penetrate the hydrophilic lid and absorb onto-the hydrophobic octylamine ligands of said core entity of the separation medium to remove these molecules from the sample, and

obtaining said target substance in a flow-through fraction of the sample.

2. The method of claim 1 , wherein said separation medium is mixed with a cation exchange chromatography media and said separation medium comprises up to 10% of the total volume of the combined separation medium and the chromatography media.

3. The method of claim 1 , wherein the sample comprises at least one of DNA and proteins which absorb onto said hydrophobic octylamine ligands in the core entity of the separation medium and are separated from said target substance in the flow-through fraction of the sample.

4. The method of claim 1 , wherein the sample comprises host cell proteins which absorb onto said hydrophobic octylamine ligands in the core entity of the separation medium and are separated from said target substance in the flow-through fraction of the sample.

5. The method of claim 1 , further comprising providing a hydrogel to said lid, wherein said hydrogel fills pores within said lid, thereby further decreasing and adjusting the size of said pores to prevent high molecular weight target substance from entering said pores.

6. The method of claim 1 , wherein magnetic particles are incorporated into said core entity.

7. The method of claim 1 , wherein said hydrophobic ligands further comprise electrostatic interaction functionality.

8. A method for separating a virus from a sample that comprises the virus and at least one of DNA and proteins, the method comprising,

applying the sample onto an agarose-based separation medium, wherein said separation medium comprises a porous core entity functionalized with hydrophobic octylamine ligands having a ligand density of greater than 90 μmole/mL and a porous hydrophilic lid covering the core entity and,

allowing the at least one of DNA and proteins from the sample to penetrate the hydrophilic lid and absorb onto the hydrophobic octylamine ligands of said core entity of the separation medium to remove the at least one of DNA and proteins from the sample, and

obtaining said virus in a flow-through fraction of the sample.

9. The method of claim 8 , wherein said separation medium is mixed with a cation exchange chromatography media and said separation medium comprises up to 10% of the total volume of the combined separation medium and the chromatography media.

10. The method of claim 8 , further comprising providing a hydrogel to said lid, wherein said hydrogel fills pores within said lid, thereby further decreasing and adjusting the size of said pores to prevent high molecular weight target substance from entering said pores.

11. The method of claim 8 , wherein magnetic particles are incorporated into said core entity.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2019
From: BERGSTROM, JAN; GLAD, GUNNAR; JOHANSSON, BO-LENNART; MALOISEL, JEAN-LUC; NORRMAN, NILS; SODERMAN, TOBIAS E.
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 050739/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2019
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 050742/0001 →
Priority Claims (1)
SE 0800923 · Apr 22, 2008 · national
Continuity (2)
Division 12988707
Related Publication 20170050121A1 · Feb 23, 2017